Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

Autor: Wilcock, Gordon K, Black, Sandra E, Hendrix, Suzanne B, Zavitz, Kenton H, Swabb, Edward A, Laughlin, Mark A
Zdroj: In Lancet Neurology 2008 7(6):483-493
Databáze: ScienceDirect